2m 2m 2m 2m 2m 2m 2m
Coherus Onco (CHRS)
NASDAQ
$1.04+$0.02 (+1.96%)
Price as of Oct 22, 2026 7:55 PM EDT- $157.6MMarket Cap
- -39.29%1-Year Change
- BiotechnologyIndustry
Coherus Onco (CHRS)
$1.04+$0.02 (+1.96%)
CHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.02 | ||
Change | +$0.02 (+2.00%) | ||
Open | $1.01 | ||
High | $1.05 | ||
Low | $1.00 | ||
Previous Close | $1.00 | ||
Volume | 1,277,239 | ||
30-Day Average Volume | 1,607,989 | ||
1-Week Change | -2.86% | ||
1-Month Change | -25.55% | ||
1-Year Change | -39.29% | ||
3-Year Change | -71.19% | ||
5-Year Change | -93.88% | ||
Fundamentals | |||
Shares Outstanding | 154.5M | ||
Total Assets | $191.2M | ||
Market Cap | $157.6M | ||
Enterprise Value | $111.9M | ||
Period: QTR TTM FY | |||
Revenue | $14.3M | ||
Net Income | -$20.6M | ||
Free Cash Flow | -$62.1M | ||
EBIT | -$18.3M | ||
EBITDA | -$17.4M | ||
Net Working Capital | $58.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 3 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue